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Abstract
This work proposes a new algorithm for automated and simultaneous phenotyping of mul-
tiple co–occurring medical conditions, also referred to as comorbidities, using clinical notes
from electronic health records (EHRs). A latent factor estimation technique, non-negative
matrix factorization (NMF), is augmented with domain constraints from weak supervision
to obtain sparse latent factors that are grounded to a fixed set of chronic conditions. The
proposed grounding mechanism ensures a one-to-one identifiable and interpretable map-
ping between the latent factors and the target comorbidities. Qualitative assessment of
the empirical results by clinical experts show that the proposed model learns clinically
interpretable phenotypes which are also shown to have competitive performance on 30 day
mortality prediction task. The proposed method can be readily adapted to any non-negative
EHR data across various healthcare institutions.
1. Introduction
Reliably querying for patients with specific medical conditions across multiple organiza-
tions facilitates many large scale healthcare applications such as cohort selection, multi-site
clinical trials, epidemiology studies etc. (Richesson et al., 2013; Hripcsak and Albers, 2013;
Pathak et al., 2013). However, raw EHR data collected across diverse populations and
multiple care-givers can be extremely high dimensional, unstructured, heterogeneous, and
noisy. Manually querying such data is a formidable challenge for healthcare professionals.
c©2016.
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EHR driven phenotypes are concise representations of medical concepts composed of
clinical features, conditions, and other observable traits facilitating accurate querying of
individuals from EHRs (NIH Health Care Systems Research Collaboratory, 2014). Efforts
like eMerge Network1, PheKB2 are well known examples of EHR driven phenotyping. Tra-
ditionally used rule–based composing methods for phenotyping require substantial time and
expert knowledge and have little scope for exploratory analyses. This motivates automated
EHR driven phenotyping using machine learning with limited expert intervention.
We propose a weakly supervised model for jointly phenotyping 30 co–occurring condi-
tions (comorbidities) observed in intensive care unit (ICU) patients. Comorbidities are a
set of co-occurring conditions in a patient at the time of admission that are not directly
related to the primary diagnosis for hospitalization (Elixhauser et al., 1998). Phenotypes
for the 30 comorbidities listed in Table 1 are derived using text-based features from clinical
notes in a publicly accessible MIMIC-III EHR database (Saeed et al., 2011). We present
a novel constrained non–negative matrix factorization (CNMF) for the EHR matrix that
aligns the factors with target comorbidities yielding sparse, interpretable, and identifiable
phenotypes.
The following aspects of our model distinguish our work from prior efforts:
1. Identifiability: A key shortcoming of standard unsupervised latent factor models
such as NMF (Lee and Seung, 2001) and Latent Dirichlet Allocation (LDA) (Blei et al.,
2003) for phenotyping is that, the estimated latent factors learnt are interchangeable and
unidentifiable as phenotypes for specific conditions of interest. We tackle identifiability
by incorporating weak (noisy) but inexpensive supervision as constraints our framework.
Specifically, we obtain weak supervision for the target conditions in Table 1 using the
Elixhauser Comorbidity Index (ECI) (Elixhauser et al., 1998) computed solely from patient
administrative data (without human intervention). We then ground the latent factors to
have a one-to-one mapping with conditions of interest by incorporating the comorbidities
predicted by ECI as support constraints on the patient loadings along the latent factors.
2. Simultaneous modeling of comorbidities: ICU patients studied in this paper
are frequently afflicted with multiple co–occurring conditions besides the primary cause
for admission. In the proposed NMF model, phenotypes for such co–occurring conditions
jointly modeled to capture the resulting correlations.
3. Interpretability: For wider applicability of EHR driven phenotyping for advance
clinical decision making, it is desirable that these phenotype definitions be clinically inter-
pretable and represented as a concise set of rules. We consider the sparsity in the represen-
tations as a proxy for interpretability and explicitly encourage conciseness of phenotypes
using tuneable sparsity–inducing soft constraints.
We evaluate the effectiveness of the proposed method towards interpretability, clinical
relevance, and prediction performance on EHR data from MIMIC-III. Although we focus
on ICU patients using clinical notes, the proposed model and algorithm are general and can
be applied on any non-negative EHR data from any population group.
1. http://emerge.mc.vanderbilt.edu/
2. http://phekb.org/
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Table 1: Target comorbidities
Congestive Heart Failure Cardiac Arrhythmias Valvular Disease Pulmonary Circulation Disorder Peripheral Vascular Disorder
Hypertension Paralysis Other Neurological Disorders Chronic Pulmonary Diseases Diabetes Uncomplicated
Diabetes Complicated Hypothyroidism Renal Failure Liver Disease (excluding bleeding) Peptic Ulcer
AIDS Lymphoma Metastatic Cancer Solid Tumor (without metastasis) Rheumatoid Arthritis
Coagulopathy Obesity Weight loss Fluid Electrolyte Disorder Blood Loss Anemia
Deficiency Anemia Alcohol abuse Drug abuse Psychoses Depression
2. Data Extraction
The MIMIC-III dataset consists of de-identified EHRs for ∼ 38, 000 adult ICU patients at
the Beth Isreal Deaconess Medical Center, Boston, Massachusetts from 2001–2012. For all
ICU stays within each admission, clinical notes including nursing progress reports, physician
notes, discharge summaries, ECG, etc. are available. We analyze patients who have stayed
in the ICU for at least 48 hours (∼ 17000 patients). We derive phenotypes using clinical
notes collected within the first 48 hours of patients’ ICU stay to evaluate the quality of
phenotypes when limited patient data is available. Further, we evaluate the phenotypes
on a 30 day mortality prediction problem. To avoid obvious indicators of mortality and
comorbidities, apart from restricting to 48 hour data, we exclude discharge summaries as
they explicitly mention patient outcomes (including mortality).
1. Clinically relevant bag-of-words features: Aggregated clinical notes from all
sources are represented as a single bag-of-words features. To enhance clinical relevance,
we create a custom vocabulary containing clinical terms from two sources (a) the System-
atized Nomenclature of Medicine-Clinical Terms (SNOMED CT), and (b) the level-0 terms
provided by the Unified Medical Language System (UMLS), consolidated into a standard
vocabulary format using Metamorphosys — an application provided by UMLS for custom
vocabulary creation.3 To extract clinical terms from the raw text, the notes were tagged for
chunking using a conditional random field tagger4. The tags are looked up against the cus-
tom vocabulary (generated from Metamorphosys) to obtain the bag-of-words representation.
Our final vocabulary has ∼3600 clinical terms.
2. Computable weak diagnosis: We incorporate domain constraints from weak su-
pervision to ground the latent factors to have a one-to-one mapping with the conditions of
interest. In the model described in Section 3, this is enforced by constraining the non-zero
entries on patient loading along the latent factors using a weak diagnosis for comorbidities.
The weak diagnoses of target comorbidities in Table 1 are obtained using ECI5, computed
solely from patient administrative data without human annotation. We refer to this index
as weak diagnoses as it is not a physician’s exact diagnosis and is subject to noise and
misspecification. Note that ECI ignores diagnoses code related to the primary diagnoses of
admission. Thus, ECI models presence and absence of conditions other than the primary
reason for admission (comorbidities). The phenotype candidates from the proposed model
can be considered as concise representations of such comorbidities.
3. See https://www.nlm.nih.gov/healthit/snomedct/ and https://www.nlm.nih.gov/research/umls/
4. https://taku910.github.io/crfpp/
5. https://git.io/v6e7q
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Notation Description
[m] for integer m Set of indices [m] = {1, 2, . . . ,m}.
∆d−1 Simplex in dimension d, ∆d−1 = {x ∈ Rd+ :
∑
xi = 1}.
x(j) Column j of a matrix X.
supp(x) Support of a vector x, supp(x) = {i : xi 6= 0}.
Observations
N , d Number of patients (∼ 17000) and features (∼ 3600), respectively.
X ∈ Rd×N+ EHR matrix from MIMIC III: Clinically relevant bag-of-words features
from notes in first 48 hours of ICU stay for N patients.
k = 1, 2, . . . ,K Indices for K = 30 comorbidities in Table 1.
Cj ⊆ [K] for j ∈ [N ] Set of comorbidities patient j is diagnosed with using ECI .
Factor matrices
W˜ ∈ [0, 1]K×N Estimate of patients’ risk for the K conditions.
A˜ ∈ Rd×K+ , b˜ ∈ Rd+ Estimate of phenotype factor matrix and feature bias vector.
Table 2: Notation used in the paper
3. Identifiable High–Throughput Phenotyping
The notation used in the paper are enumerated in Table 2. In summary, for each patient
j ∈ [N ], (a) the bag-of-words features from clinical notes is represented as column x(j) of
EHR matrix X ∈ Rd×N+ , and (b) the list of comorbidities diagnosed using ECI is denoted
as Cj ⊆ [K]. Let an unknown W∗ ∈ [0, 1]K×N represent the risk of N patients for K
comorbidities of interest; each entry w∗kj lies in the interval [0, 1], with 0 and 1 indicating
no-risk and maximum-risk, respectively, of patient j being afflicted with condition k. If
C∗j ⊆ [K] denotes an accurate diagnosis for patient j, then w∗(j) satisfies supp(w∗(j)) ⊆ C∗j .
Definition 1 (EHR driven phenotype) EHR driven phenotypes forK co–occurring con-
ditions are a set of vectors {a∗(k) ∈ Rd+ : k ∈ [K]}, such that for a patient j afflicted with
conditions C∗j ⊆ [K],
E[x(j)|w∗(j)] =∑k∈C∗j w∗kja∗(k) + b∗, (1)
where b∗ is a bias representing the feature component observed independent of the K target
conditions. A∗ ∈ Rd×K with a∗(k) as columns is referred as the phenotype factor matrix.
Note that we explicitly model a feature bias b∗ to capture frequently occurring terms that
are not discriminative of the target conditions, e.g., temperature, pain, etc.
Cost Function The bag-of-words features are represented as counts in the EHR matrix
X. We consider a factorized approximation of X parametrized by matrices A ∈ Rd×K+ ,
W ∈ RK×N+ and b ∈ Rd+ as Y = AW + b1>, where 1 denotes a vector of all ones of
appropriate dimension. The approximation error of the estimate is measured using the
I–divergence defined as follows:
D(X,Y) =∑ij yij − xij − xij log yijxij . (2)
Minimizing the I–divergence is equivalent to maximum likelihood estimation under a Pois-
son distributional assumption on individual entries of the EHR matrix parameterized by
Y = AW + b1> (Banerjee et al., 2005).
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Algorithm 1 Phenotyping using constrained NMF.
Input: X, {Cj : j ∈ [N ]} and paramter λ. Initialization: A(0), b(0).
while Not converged do
W(t) ← arg minWD(X,A(t−1)W + b(t−1)1>) s.t. W ∈ [0, 1]K×N , supp(wj) = Cj , ∀j
A(t), b(t) ← arg minA,b≥0D(X,AW(t) + b1>) s.t. a(k)j ∈ λ∆d−1, ∀k
Phenotypes For the K comorbidities, columns of A, {a(k)}k∈[K] are proposed as candi-
date phenotypes derived from the EHR X, i.e. approximations to {a∗(k)}k∈[K].
Constraints The following constraints are incorporated in learning A and W.
1. Support Constraints: The non-negative rank–K factorization of X is ‘grounded’ to
K target comorbidities by constraining the support of risk w(j) corresponding to patient j
using weak diagnosis Cj from ECI as an approximation of the conditions in Definition 1.
2. Sparsity Constraints: Scaled simplex constraints are imposed on the columns of A
with a tuneable parameter λ > 0 to encourage sparsity of phenotypes. Restricting the
patient loadings matrix as W ∈ [0, 1]K×N not only allows to interpret the loadings as the
patients’ risk, but also makes simplex constraints effective in a bilinear optimization.
Simultaneous phenotyping of comorbidities using constrained NMF is posed as follows:
A˜,W˜, b˜ =argminA≥0,W≥0,b≥0 D(X,AW + b1>)
s.t. supp(w(j)) = Cj ∀j ∈ [N ], W ∈ [0, 1]K×N ,
a(k) ∈ λ∆d−1 ∀j ∈ [K],
(3)
The optimization in (3) is convex in either factor with the other factor fixed. It is solved
using alternating minimization with projected gradient descent (Parikh and Boyd, 2014;
Lin, 2007). See complete algorithm in Algorithm 1. The proposed model in general can
incorporate any weak diagnosis of medical conditions. In this paper, we note that, since we
use ECI, the results are not representative of the primary diagnoses at admission.
4. Empirical Evaluation
The estimated phenotypes are evaluated on various metrics. We denote the model learned
using Algorithm 1 with a given parameter λ > 0 as λ–CNMF. The following baselines are
used for comparison:
1. Labeled LDA (LLDA): LLDA (Ramage et al., 2009) is the supervised counterpart
of LDA, a probabilistic model to estimate topic distribution of a corpus. It assumes that
word counts of documents arise from multinomial distributions. It incorporates supervision
on topics contained in a document and can be naturally adapted for phenotyping from bag-
of-words clinical features, where the topic–word distributions form candidate phenotypes.
While LLDA assumes that the topic loadings of a document lie on the probability simplex
∆K−1, λ–CNMF allows each patient–condition wkj loading to lie in [0, 1]. In interpreting
the patient loading as a disease risk, the latter allows patients to have varying levels of
disease prevalence. Also, LLDA can induce sparsity only indirectly via a hyperparameter
β of the informative prior on the topic–word distributions. While this does not guarantee
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sparse estimates, we obtain reasonable sparsity on LLDA estimates. We use the Gibbs
sampling code from MALLET (McCallum, 2002) for inference. For a fair comparison to
CNMF which uses an extra bias factor, we allow LLDA to model an extra topic shared by
all documents in the corpus.
2. NMF with support constraints (NMF+support): This NMF model incorpo-
rates non–negativity and support constraints from weak supervision but not the sparsity
inducing constraints on the phenotype matrix. This allows to study the effect of sparsity
inducing constraints for interpretability. On the other hand, imposing sparsity without our
grounding technique does not yield identifiable topics and hence is not studied as a baseline.
3. Multi-label Classification (MLC): This baseline treats weak supervision (from
ECI) as accurate labels in a fully supervised model. A sparsity inducing `1 regularized
logistic regression classifier is learned for each condition independently. The learned weight
vector for each condition k determines importance of clinical terms towards discriminating
patients with condition k and are treated as candidate phenotypes for condition k.
The weak supervision does not account for the primary diagnosis for admission in the
ICU population as the ECI ignores primary diagnoses at admission (Elixhauser et al., 1998).
However, the learning algorithm can be easily modified to account for the primary diagnoses,
if required by using a modified form of supervision or absorbing the effects in an additional
additive term appended to the model. Nevertheless, the proposed model generates highly
interpretable phenotypes for comorbidities. Finally, to mitigate the effect of local minima,
whenever applicable, for each model, the corresponding algorithm was run with 5 random
initializations and results providing the lowest divergence were chosen for comparison.
4.1 Interpretability–accuracy trade–off
Sparsity of the latent factors is used as a proxy for interpretability of phenotypes. Sparsity
is measured as the median of the number of non–zero entries in columns of the phenotype
matrix A (lower is better). The λ parameter in λ–CNMF controls the sparsity by imposing
scaled simplex constraints on A. CNMF was trained on multiple λ in the range of 0.1 to 1.
Stronger sparsity-inducing constraints results in worse fit to the cost function. This trade–
off is indeed observed in all models (see A for details). For all models, we pick estimates
with lowest median sparsity while ensuring that the phenotype candidate for every condition
is represented by at least 5 non-zero clinical terms.
4.2 Clinical relevance of phenotypes
We requested two clinicians to evaluate the candidate phenotypes based on the top 15
terms learned by each model. The ratings were requested on a scale of 1 (poor) to 4 (excel-
lent). The experts were asked to rate based on whether the terms are relevant towards the
corresponding condition and whether the terms are jointly discriminative of the condition.
Figure 1 shows the summary of qualitative ratings obtained for all models. For each model,
we show two columns (corresponding to two experts). The stacked bars show the histogram
of the ratings for the models. Nearly 50% of the phenotypes learned from our model were
rated ‘good’ or better by both annotators. In contrast, NMF with support constraints but
without sparsity inducing constraints hardly learns clinically relevant phenotypes. The pro-
posed model 0.4–CNMF also received significantly higher number of ‘excellent’ and ‘good’
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Figure 1: Qualitative Ratings from Annotation: The two bars represent the ratings provided by the
two annotators. Each bar is a histogram of the scores for the 30 comorbidities sorted by scores.
0.4–CNMF LLDA MLC NMF
0.4–CNMF 0 28 20 44
LLDA 7 0 12 35
MLC 6 21 0 42
NMF+support 1 0 1 0
Table 3: Relative Rankings Matrix: Each row of the table is the number of times the model along
the row was rated strictly better than the model along the column by clinical experts, e.g., column 3
in row 2 implies that LLDA was rated better than MLC 12 times over all conditions by all experts.
ratings from both experts. Although LLDA and MLC estimate sparse phenotypes, they
are not at par with λ–CNMF. Table 3 shows a summary of relative rankings for all models.
Each cell entry shows the number of times the model along the corresponding row was rated
strictly better than that along the column. 0.4–CNMF is better than all three baselines.
The supervised baseline MLC outperforms LLDA even though LLDA learns comorbidities
jointly suggesting that the simplex constraint imposed by LLDA may be restrictive.
Figure 2 is an example of a phenotype (top 15 terms) learned by all models for psychoses.
For this condition, the proposed model was rated “excellent” and strictly better than both
LLDA and MLC by both annotators while LLDA and MLC ratings were tied. However,
the phenotype for Hypertension (in Figure 3) learned by 0.4–CNMF has more terms related
to ‘Renal Failure’ or ‘End Stage Renal Disease’ rather than hypertension. One of our
annotators pointed out that “Candidate 1 is a fairly good description of renal disease,
which is an end organ complication of hypertension”, where the anonymized Candidate
1 refers to 0.4–CNMF. Exploratory analysis suggests that hypertension and renal failure
are the most commonly co-occurring set of conditions. Over 93% of patients that have
hypertension (according to ECI) also suffer from Renal Failure. Thus, our model is unable
to distinguish between highly co-occurring conditions. Other baselines were also rated
poorly for hypertension, while LLDA was rated only slightly better. More examples of
phenotypes are provided in B.
7
schizophrenia
bipolar_disorder
overdose
schizoaffective_disorder
paranoia
psychosis
lithium_toxicity
poisoning
personality
serotonin_syndrome
paranoid_schizophrenia
mental_retardation
suicide
psychiatric_disease
suicide_attempt
0.4-CNMF
altered_mental_status
fever
agitated
schizophrenia
agitation
stress_ulcer
overdose
bipolar_disorder
delirium
mental_status
aspiration
depression
hyponatremia
unresponsive
leukocytosis
LLDA
bipolar_disorder
schizophrenia
flat_affect
overdose
schizoaffective_disorder
hematomas
psychosis
lvh
metastatic_prostate_cancer
diastolic_dysfunction
agitated
lethargy
suicidal_ideation
ileus
acquired_immunodeficiency_syndrome
MLC
pain
pneumothorax
agitated
edema
atelectasis
anxiety
confused
aspiration
opacity
pleural_effusion
agitation
trauma
schizophrenia
stress_ulcer
bipolar_disorder
NMF+support
Figure 2: Phenotypes learned for ‘Psychoses’ (words are listed in order of importance)
esrd
cri
ckd
chronic_renal_insufficiency
chronic_renal_failure
end_stage_renal_disease
acute_on_chronic_renal_failure
chronic_kidney_disease
cns_lymphoma
jaw_pain
amyloidosis
skin_impairment
glomerulonephritis
hyperparathyroidism
holosystolic_murmur
0.4-CNMF
chf
htn
hypertension
chest_pain
cad
crackles
sob
cp
pulmonary_edema
ischemia
stress_ulcer
heart_failure
gib
dyspnea
nausea
LLDA
cri
av_fistula
chronic_renal_insufficiency
ckd
left_ventricular_hypertrophy
renal_insufficiency
esrd
chronic_renal_failure
acute_on_chronic_renal_failure
sinus_rhythm
cardiomegaly
left_atrial_abnormality
jaw_pain
htn
renal_failure
MLC
htn
pain
intraventricular_hemorrhage
pulmonary_edema
hypoxia
hydrocephalus
hypotension
cough
acute_renal_failure
sob
confused
stenosis
herniation
bleed
hemorrhage
NMF+support
Figure 3: Phenotypes learned for ‘Hypertension’
4.3 Mortality prediction
To quantitatively evaluate the utility of the learned phenotypes, we consider the 30 day
mortality prediction task. We divide the EHR into 5 cross-validation folds of 80% training
and 20% test patients. As this is an imbalanced class problem, the training–test splits are
stratified by mortality labels. For each split, all models were applied on the training data to
obtain phenotype candidates A˜ and feature biases b˜. For each model, the patient loadings W˜
along the respective phenotype space (A˜, b˜) are used as features to train a logistic regression
classifier for mortality prediction. For CNMF and NMF+support, these are obtained as
Wtrain/test = argminW∈[0,1]K×ND(A˜W + b˜1>,Xtrain/test) for fixed (A˜, b˜). For LLDA, these
are obtained using Gibbs sampling with fixed topic–word distributions. For MLC, the
predicted class probabilities of the comorbidities are used as features. Additionally, we
train a logistic regression classifier using the full EHR matrix as features.
We clarify the following points on the methodology: (1) A˜ is learned on the patients
in the training dataset only, hence there is no information leak from test patients into
training. (2) Test patients’ comorbidities from ECI are not used as support constraints on
their loadings. (3) Regularized logistic regression classifiers are used to learn models for
mortality prediction. The regularization parameters are chosen via grid-search.
The performance of the above baselines trained on `2 regularized logistic regression over
a 5-fold cross-validation is reported in Table 4: rows 1–5. The classifier trained on the full
EHR unsurprisingly outperforms all baselines as it uses richer high dimensional informa-
tion. All phenotyping baselines, except NMF+support, show comparable performance on
mortality prediction which in spite of learning on a small number of 30 features, is only
slightly worse than predictive performance of full EHR with ∼ 3500 features.
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Model AUROC Sensitivity Specificity
1. 0.4–CNMF 0.63(0.02) 0.59(0.04) 0.62(0.03)
2. NMF+support 0.52(0.02) 0.56(0.13) 0.51(0.14)
3. LLDA 0.64(0.02) 0.62(0.03) 0.61(0.05)
4. MLC 0.66(0.01) 0.62(0.06) 0.62(0.05)
5. Full EHR 0.72(0.02) 0.69(0.02) 0.63(0.04)
6. CNMF+Full EHR (`1, C = 0.1) 0.72(0.02) 0.61(0.09) 0.71(0.07)
Table 4: 30 day mortality prediction: 5–fold cross-validation performance of logistic regression classi-
fiers. Classifiers for 0.4–CNMF and competing baselines (NMF+support, LLDA, MLC) were trained
on the 30 dimensional phenotype loadings as features. Full EHR denotes the baseline classifier (`1-
regularized logistic regression) using full ∼ 3500 dimensional EHR as features. CNMF+Full EHR
denotes the performance of the `1-regularized classifier learned on Full EHR augmented with CNMF
features (hyperparameter was manually tuned to match performance of the Full EHR model).
Augmented features for mortality prediction (CNMF+Full EHR) Unsurpris-
ingly, Table 4 suggests that the high dimensional EHR data has additional information
towards mortality prediction which are lacking in the 30 dimensional features generated via
phenotyping. To evaluate whether this additional information can be captured by CNMF
if augmented with a small number of raw EHR features, we train a mortality prediction
classifier using `1 regularized logistic regression on CNMF features/loadings combined with
raw bag–of–words features, with parameters tuned to match the performance of the full
EHR model. The results are reported in the final row of Table 4.
In exploring the weights learned by the classifier for all features, we observe that only
8.3% of the features corresponding to raw EHR based bag-of-words features have non–
zero weights. This suggests that comorbidities capture significant amount of predictive
information on mortality and achieve comparable performance to full EHR model with a
small number of additional terms. See Figure 35 in Appendix showing the weights learned
by the classifier for all features. Figure 4 shows comorbidities and EHR terms with top
magnitude weights learned by the CNMF+full EHR classifier. For example, it is interesting
to note that the top weighted EHR term – dnr or ‘Do Not Resuscitate’ is not indicative of
any comorbidity but is predicitive of patient mortality.
5. Discussion and Related Work
Supervised learning methods like Carroll et al. (2011); Kawaler et al. (2012); Chen et al.
(2013) or deep learning methods (Lipton et al., 2015; Kale et al., 2015; Henao et al., 2015) for
EHR driven phenotyping require expert supervision. Although unsupervised methods like
NMF (Anderson et al., 2014) and non–negative tensor factorization (Kolda and Bader, 2009;
Harshman, 1970) are inexpensive alternatives (Ho et al., 2014a,b,c; Luo et al., 2015), they
pose challenges with respect to identifiability, interpretability and computation, limiting
their scalability.
Most closely related to our paper is work by Halpern et al. (2016b) which is a semi-
supervised algorithm for learning the joint distribution on conditions, requiring only that
a domain expert specify one or more ‘anchor’ features for each condition (no other labeled
data). An ‘anchor’ for a condition is a set of clinical features that when present are highly
indicative of the target condition, but whose absence is not a strong label for absence of
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Figure 4: Top magnitude weights on (a) EHR and (b) CNMF features in CNMF+Full EHR classifier
the target condition (Halpern et al., 2014, 2016a). For example, the presence of insulin
medication is highly indicative of diabetes, but the converse is not true. Joshi et al. (2015)
use a similar supervision approach for comorbidities prediction. Whereas the conditions in
Halpern et al. (2016b) are binary valued, in our work they are real-valued between 0 and 1.
Furthermore, we assume that the support of the conditions is known in the training data.
Our approach achieves identifiability using support constraints to ground the latent fac-
tors and interpretability using sparsity constraints. The phenotypes learned are clinically
interpretable and predictive of mortality when augmented with a sparse set of raw bag-of-
words features on unseen patient population. The model outperforms baselines in terms
of clinical relevance according to experts and significantly better than the model which
includes supervision but no sparsity constraints. The proposed method can be easily ex-
tended to other non–negative data to obtain more comprehensive phenotypes. However,
it was observed that the algorithm does not discriminate between frequently co–occurring
conditions, e.g. renal failure and hypertension. Further, the weak supervision (using ECI)
does not account for the primary diagnoses of admission. Additional model flexibility to
account for a primary condition in explaining the observations could potentially improve
performance. Addressing the above limitations along with quantitative evaluation of risk for
disease prediction, and understanding conditions for uniqueness of phenotyping solutions
are interesting areas of follow-up work.
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Appendix A. Phenotype Sparsity
As suggested in Section 4.1, there is an inherent tradeoff between fit to the cost function
and desired sparsity. The trade-off is made explicit for λ–CNMF in Figure 5. The sparsity
of LLDA is controlled by tuning the hyperparameter (β) of the word-topic multinomial
parameters (Blei et al., 2003) and for MLC via the `1 regularization parameter η. A smaller
value of β ensures that the word-topic probabilities are sparse. As the value of β is increased,
sparsity decreases (i.e. number of non-zero elements increases). For logistic regression
(used by MLC), as the `1 regularization parameter increases, sparsity increases. Figure 6a
demonstrates the sparsity of the estimated phenotypes for LLDA and Figure 6b shows that
of logistic regression. We choose phenotypes obtained at β = 1 × 10−8 and η = 100 for
qualitative annotation. The parameters were chosen to achieve the lowest median sparsity
while ensuring that for each chronic condition, the corresponding phenotype candidate is
represented by at least 5 non-zero clinical terms. Our fourth baseline (NMF + support)
did not estimate sparse phenotypes and does not have a tuneable sparsity parameter (but
were nevertheless annotated for qualitative evaluation). The proposed model provides the
best sparsity among all baselines.
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Figure 5: Sparsity–Accuracy Trade–off. Sparsity of the model is measured as the median of the
number of non-zero entries in columns of the phenotype matrix A. (a) shows a box plots of the
median sparsity across the 30 chronic conditions for varying λ values. The median and third–
quartile values are explicitly noted on the plots. (b) divergence function value of the estimate from
Algorithm 1 plotted against λ parameter.
Appendix B. Sample Phenotypes for Baseline Models
Figures 7–33 show the top 15 terms learned for all target chronic conditions for the pro-
posed model and baselines. The sparsity level chosen is based on the criterion described in
Section 4.1. For all conditions, the terms are ordered in decreasing order of importance as
learned by the models.
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Figure 6: Phenotype sparsity for baseline models
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Figure 7: Learned Phenotypes for Liver Disease
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Figure 8: Learned Phenotypes for Solid Tumor
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Figure 9: Learned Phenotypes for Metastatic Cancer
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Figure 10: Learned Phenotypes for Chronic Pulmonary Disorder
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Figure 11: Learned Phenotypes for Alcohol Abuse
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Figure 12: Learned Phenotypes for Diabetes Uncomplicated
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Figure 13: Learned Phenotypes for Diabetes Complicated
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Figure 14: Learned Phenotypes for Peripheral Vascular Disorder
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Figure 15: Learned Phenotypes for Renal Failure
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Figure 16: Learned Phenotypes for Other Neurological Disorders
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Figure 17: Learned Phenotypes for Cardiac Arrhythmias
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Figure 18: Learned Phenotypes for Drug Abuse
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Figure 19: Learned Phenotypes for Paralysis
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Figure 20: Learned Phenotypes for AIDS
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Figure 21: Learned Phenotypes for Fluid Electrolyte Disorders
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Figure 22: Learned Phenotypes for Rheumatoid Arthritis
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Figure 23: Learned Phenotypes for Lymphoma
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Figure 24: Learned Phenotypes for Coagulopathy
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Figure 25: Learned Phenotypes for Obesity
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Figure 26: Learned Phenotypes for Pulmonary Circulation Disorder
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Figure 27: Learned Phenotypes for Valvular Disease
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Figure 28: Learned Phenotypes for Peptic Ulcer
chf
diastolic_heart_failure
hypotension
pancolitis
mrsa_pneumonia
cad
jaw_pain
black_tarry_stools
chronic_respiratory_failure
facial_flushing
femoral_fracture
subglottic_stenosis
gout_flare
chronic_inflammation
tumor_lysis_syndrome
0.4-CNMF
chf
pneumonia
pulmonary_edema
pleural_effusion
sepsis
pna
hypoxia
sob
crackles
respiratory_failure
atelectasis
cad
aspiration
congestive_heart_failure
fever
LLDA
cardiomegaly
congestive_heart_failure
chf
pulmonary_edema
calcifications
hip_fracture
obstruction
dnr
rheumatoid_arthritis
cad
bm
crackles
afebrile
pleural_effusion
obese
MLC
pain
pneumothorax
edema
atelectasis
pleural_effusion
sepsis
cough
pneumonia
chf
pulmonary_edema
sob
crackles
afebrile
bleeding
subarachnoid_hemorrhage
NMF+support
Figure 29: Learned Phenotypes for Congestive Heart Failure
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Figure 30: Learned Phenotypes for Hypothyroidism
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Figure 31: Learned Phenotypes for Weight loss
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Figure 32: Learned Phenotypes for Deficiency Anemias
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Figure 33: Learned Phenotypes for Blood Loss Anemia
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Figure 34: Learned Phenotypes for Depresssion
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Appendix C. Augmented Mortality Prediction
Figure 35 shows weights learned by the classifier for all features. The weights shaded red cor-
respond to phenotypes and are relatively high compared to raw notes based features (shaded
blue), indicating that comorbidities capture significant amount of predictive information on
mortality and achieve comparable performance to full EHR model when augmented with
additional raw clinical terms.
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Figure 35: Weights learned by the CNMF+Full EHR classifier for all features. The weights shaded
red correspond to phenotypes.
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